Nephros Inc. (NEPH)
NASDAQ: NEPH
· Real-Time Price · USD
4.14
-0.02 (-0.48%)
At close: Jun 25, 2025, 2:04 PM
Nephros Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Other Revenue Revenue | 121K | 97K | 46K | 121K | 40K | 77K | 29K |
| Other Revenue Revenue Growth | +24.74% | +110.87% | -61.98% | +202.50% | -48.05% | +165.52% | n/a |
| Royalty and Other Revenues Revenue | 127K | n/a | 46K | n/a | n/a | 152K | n/a |
| Royalty and Other Revenues Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.25M | 1.87M | 1.72M | 1.94M | 2.14M | 2.41M | 2.14M | 2.24M | 2.12M | 1.79M | 1.74M | 2.07M | 2.35M | 1.97M | 1.89M | 1.85M | 2M | 1.36M | 1.54M | 1.61M | 1.95M | 1.43M | 1.79M | 1.4M | 1.5M | 1.1M | 1.07M | 1.09M | 1.26M | 893K | 753K | 880K | 770K | 620K | 652K | 804K | 777K | 892K | 974K | 735K | 843K |
| Selling, General, and Administrative Revenue Growth | +20.41% | +8.77% | -11.33% | -9.38% | -11.16% | +12.82% | -4.56% | +5.41% | +18.86% | +2.52% | -15.80% | -11.84% | +19.49% | +3.86% | +2.05% | -7.25% | +46.77% | -11.79% | -4.10% | -17.44% | +36.75% | -20.20% | +27.37% | -6.65% | +37.01% | +2.62% | -2.02% | -13.41% | +41.10% | +18.59% | -14.43% | +14.29% | +24.19% | -4.91% | -18.91% | +3.47% | -12.89% | -8.42% | +32.52% | -12.81% | n/a |
| Research and Development Revenue | 295K | 252K | 188K | 254K | 212K | 208K | 205K | 221K | 239K | 359K | 252K | 431K | 578K | 491K | 632K | 487K | 556K | 609K | 751K | 836K | 563K | 764K | 777K | 793K | 756K | 546K | 352K | 352K | 289K | 258K | 237K | 277K | 231K | 316K | 241K | 254K | 269K | 244K | 226K | 164K | 192K |
| Research and Development Revenue Growth | +17.06% | +34.04% | -25.98% | +19.81% | +1.92% | +1.46% | -7.24% | -7.53% | -33.43% | +42.46% | -41.53% | -25.43% | +17.72% | -22.31% | +29.77% | -12.41% | -8.70% | -18.91% | -10.17% | +48.49% | -26.31% | -1.67% | -2.02% | +4.89% | +38.46% | +55.11% | 0.00% | +21.80% | +12.02% | +8.86% | -14.44% | +19.91% | -26.90% | +31.12% | -5.12% | -5.58% | +10.25% | +7.96% | +37.80% | -14.58% | n/a |